Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: A retrospective study of 158 patients

International Journal of Radiation Oncology Biology Physics

Volumn 55, Issue 2, 2003, Pages 329-336

  Seong, Jinsil ^a   Park, Hee Chul ^a   Han, Kwang Hyub ^a   Chon, Chae Yoon ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Hepatocellular carcinoma; Prognostic factor; Radiotherapy; Survival

Indexed keywords

CARCINOGENS; PATIENT TREATMENT; TUMORS;

PROGONOSTIC FACTORS;

RADIOTHERAPY;

ACUTE TOXICITY; ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CHRONIC TOXICITY; COLITIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GASTRODUODENAL ULCER; GASTROENTERITIS; HUMAN; LEUKOPENIA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NAUSEA; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; STATISTICAL ANALYSIS; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

ADULT; AGED; ANALYSIS OF VARIANCE; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0037298449     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)03929-9     Document Type: Article

References (27)

1. Cook G.C., Moosa B. Hepatocellular carcinoma One of the world's most common malignancies . Am J Med. 233:1985;705-708.
2. Dusheiko G.M., Hobbs K.E., Dick R., et al. Treatment of small hepatocellular carcinoma. Lancet. 340:1992;285-288.
3. Mori W. Cirrhosis and primary cancer of the liver Comparative study in Tokyo and Cincinnati . Cancer. 55:1967;627-631.
4. Venook A.P. Treatment of hepatocellular carcinoma Too many options? J Clin Oncol. 12:1994;1323-1334.
5. Wellwood J.M., Cady B., Oberfield R.A. Treatment of primary liver cancer Response with regional chemotherapy . J Clin Oncol. 5:1979;25-31.
6. Atiq O.T., Kemeny N., Niedzwiecki D., et al. Treatment of unresectable primary liver cancer with intrahepatic fluorodeoxyuridine and mitomycin C through an implanted pump. Cancer. 69:1992;920-924.
7. Ohto M., Yoshikawa M., Saisho H., et al. Non-surgical treatment of hepatocellular carcinoma in cirrhotic patients. World J Surg. 19:1995;42-46.
8. Ikeda K., Kumada H., Saitoh S., et al. Effects of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. Cancer. 68:1991;2150-2154.
9. Cochrane A.M.G., Murray-Lyon I.M., Brinkley D.M., et al. Quadruple chemotherapy versus radiotherapy in treatment of primary hepatocellular carcinoma. Cancer. 40:1977;609-614.
10. Friedman M.A., Volberding P.A., Cassidy M.J., et al. Therapy for hepatocellular cancer with intrahepatic arterial adriamycin and 5-fluorouracil combined with whole-liver irradiation A Northern California Oncology Group study . Cancer Treat Rep. 63:1979;1885-1888.
11. Stillwagon G.B., Order S.E., Guse C.G., et al. Hepatocellular cancers treated by radiation and chemotherapy combinations Toxicity and response: a Radiation Therapy Oncology Group (RTOG) study . Int J Radiat Oncol Biol Phys. 194:1989;1223-1229. 17.
12. Ho S., Lau W.Y., Leung T.W., et al. Internal radiation therapy for patients with primary or metastatic hepatic cancer A review . Cancer. 83:1998;1894-1907.
13. Tanaka N., Matsuzaki Y., Chuganzi Y., et al. Proton irradiation for hepatocellular carcinoma. Lancet. 340:1992;1358.
14. Matsuura M., Nakajima N., Arai K., et al. The usefulness of radiation therapy for hepatocellular carcinoma. Hepatogastroenterology. 45:1998;791-796.
15. Seong J., Keum K.C., Han K.H., et al. Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 43:1999;393-397.
16. Seong J., Park H.C., Han K.H., et al. Local radiotherapy for unresectable hepatocellular carcinoma patients who failed with transcatheter arterial chemoembolization. Int J Radiat Oncol Biol Phys. 47:2000;1331-1335.
17. Dawson L.A., McGinn C.J., Normolle D., et al. Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol. 18:2000;2210-2218.
18. Kaplan E., Meier P. Nonparametric estimations from incomplete observations. Am Stat Assoc J. 53:1958;457-481.
19. Cox D. Regression models and life-tables. J Roy Stat Soc. 34:1972;187-220.
20. Ho S., Lau W.Y., Leung T.W., et al. Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer. Eur J Nucl Med. 24:1997;293-298.
21. Cheng J.C.-H., Chuang V.P., Cheng S.H., et al. Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 47:2000;435-442.
22. Abrams R.A., Cardinale R.M., Enger C., et al. Influence of prognostic grouping and treatment results in the management of unresectable hepatoma Experience with cis-platinum-based chemoradiotherapy in 76 patients . Int J Radiat Oncol Biol Phys. 39:1997;1077-1085.
23. Robertson J.M., Lawrence T.S., Dworzanin L.M., et al. Treatment of primary hepatobiliary cancers with conformal radiation therapy and regional chemotherapy. J Clin Oncol. 11:1993;1286-1293.
24. Order S.E., Stillwagon G.B., Klein J.L., et al. Iodine 131 antiferritin, a new treatment modality in hepatoma A Radiation Therapy Oncology Group study . J Clin Oncol. 13:1985;1573-1582.
25. Seong J., Park H.C., Han K.H., et al. Determination of optimal dose in external radiotherapy for hepatocellular carcinoma. J Hepatol. 34:(Suppl. 1):2001;102a.
26. Schoniger-Hekele M., Muller C., Kutilek M., et al. Hepatocellular carcinoma in central Europe Prognostic features and survival . Gut. 48:2001;103-109.
27. Wong J.W., Sharp M.B., Jaffray D.A., et al. The use of active breathing control (ABC) to reduce margin for breathing motion. Int J Radiat Oncol Biol Phys. 44:1999;911-919.